Announce Date | 06/12/2024 |
EPS Normalized Actual | $10.96 (Beat by $0.11) |
EPS GAAP Actual | $10.96 (Beat by $0.11) |
Revenue Actual | $8.103B |
Revenue Surprise | Beat by $8103M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Oct 2028 | 0 | INF | 0 | 0 | 5 |
Oct 2027 | 78.41 | 1.93 | 73.56449 | 83.74842 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2022 (May 2022) | 6.35 | 6.35 | 8.103B | 18.43% | 8103M |
FQ1 2022 (Jan 2022) | 5.82 | 5.82 | 7.706B | 13.64% | 7706M |
FQ4 2021 (Oct 2021) | 4.65 | 4.65 | 7.407B | 12.69% | 7407M |
FQ3 2021 (Aug 2021) | 4.38 | 4.38 | 6.778B | 14.12% | 6778M |
FQ2 2021 (May 2021) | 3.46 | 3.46 | 6.61B | 13.13% | 6610M |
FQ1 2021 (Jan 2021) | 3.2 | 3.2 | 6.655B | 11.98% | 6655M |
FQ4 2020 (Oct 2020) | 3.09 | 3.09 | 6.467B | 10.69% | 6467M |
FQ3 2020 (Aug 2020) | 1.52 | 1.52 | 5.821B | 5.26% | 5821M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Nov 2026) | 16.66798 | -- | 15.973 | 17.37983 | 14 |
FQ3 2026 (Aug 2026) | 15.62364 | -- | 14.9722 | 16.29089 | 7 |
FQ2 2026 (May 2026) | 15.03477 | -- | 14.40789 | 15.67687 | 7 |
FQ1 2026 (Feb 2026) | 15.48653 | -- | 14.84081 | 16.14792 | 10 |
FQ4 2025 (Nov 2025) | 15.04209 | -- | 14.4149 | 15.6845 | 15 |
FQ3 2025 (Aug 2025) | 14.23071 | -- | 13.63735 | 14.83847 | 8 |
FQ2 2025 (May 2025) | 13.6678 | -- | 13.09791 | 14.25152 | 8 |
FQ1 2025 (Feb 2025) | 13.7226 | -- | 13.15043 | 14.30866 | 11 |
FQ4 2024 (Nov 2024) | 13.79247 | -- | 12.99488 | 14.33717 | 13 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Nov 2026) | 15.75B | -- | 15.25B | 16.27B | 10 |
FQ3 2026 (Aug 2026) | 14.99B | -- | 14.51B | 15.48B | 16 |
FQ2 2026 (May 2026) | 14.58B | -- | 14.11B | 15.06B | 8 |
FQ1 2026 (Feb 2026) | 14.8B | -- | 14.33B | 15.29B | 11 |
FQ4 2025 (Nov 2025) | 14.49B | -- | 14.02B | 14.96B | 7 |
FQ3 2025 (Aug 2025) | 13.91B | -- | 13.46B | 14.37B | 11 |
FQ2 2025 (May 2025) | 13.56B | -- | 13.12B | 14.01B | 7 |
FQ1 2025 (Feb 2025) | 13.65B | -- | 13.21B | 14.1B | 7 |
FQ4 2024 (Nov 2024) | 14.02B | -- | 13.4B | 14.45B | 14 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | 6.35 | 6.35 | 100% | |
FQ1 2022 (Jan 2022) | 5.82 | 5.82 | 100% | |
FQ4 2021 (Oct 2021) | 4.65 | 4.65 | 100% | |
FQ3 2021 (Aug 2021) | 4.38 | 4.38 | 100% | |
FQ2 2021 (May 2021) | 3.46 | 3.46 | 100% | |
FQ1 2021 (Jan 2021) | 3.2 | 3.2 | 100% | |
FQ4 2020 (Oct 2020) | 3.09 | 3.09 | 100% | |
FQ3 2020 (Aug 2020) | 1.52 | 1.52 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2022 (May 2022) | $0B | $8.1B | $8103M | 100% |
FQ1 2022 (Jan 2022) | $0B | $7.71B | $7706M | 100% |
FQ4 2021 (Oct 2021) | $0B | $7.41B | $7407M | 100% |
FQ3 2021 (Aug 2021) | $0B | $6.78B | $6778M | 100% |
FQ2 2021 (May 2021) | $0B | $6.61B | $6610M | 100% |
FQ1 2021 (Jan 2021) | $0B | $6.66B | $6655M | 100% |
FQ4 2020 (Oct 2020) | $0B | $6.47B | $6467M | 100% |
FQ3 2020 (Aug 2020) | $0B | $5.82B | $5821M | 100% |